AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX)

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / SPONSORED ADR
Total 13F shares
2,909,034
Share change
+600,935
Total reported value
$6,339,653
Price per share
$2.18
Number of holders
19
Value change
+$1,319,917
Number of buys
11
Number of sells
5

Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) as of Q2 2020

As of 30 Jun 2020, AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,909,034 shares. The largest 10 holders included Hikari Power Ltd, NEA Management Company, LLC, Omnia Family Wealth, LLC, United Asset Strategies, Inc., RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, Squarepoint Ops LLC, CITADEL ADVISORS LLC, Virtu Financial LLC, and ENVESTNET ASSET MANAGEMENT INC. This page lists 19 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.